The Office of Technology Transfer & Commercialization helps move Georgia State discoveries into the marketplace by licensing these inventions to industry partners or helping create new businesses to drive them forward.
- Infectious diseases (COVID-19, Ebola, influenza, measles and respiratory syncytial virus)
- Inflammatory diseases (inflammatory bowel disease and chronic obstructive pulmonary disease)
- Sexually transmitted infections
- Cardiovascular diseases and diabetes
Our research centers are focused on microbial pathogenesis, translational immunology, antiviral drug development and inflammation, immunity and infection.
1 OF 6 NATIONAL INSTITUTES
The Institute for Biomedical Science is 1 of 6 National Institutes of Health-funded cooperative research centers nationwide that were created to advance development of vaccines for sexually transmitted infections.
Working Together to Improve Human Health
Our researchers are developing new vaccines, diagnostics and therapeutics to tackle some of the world’s biggest health issues. To bring these biomedical inventions to the market, they’d like to work with pharmaceutical and biotech companies, foundations, industry sponsors and donors who want to improve the health of people worldwide. Learn more about our patents and inventions.
University Tech Transfer and Commercialization
We’re ready to partner with you. Please contact us to collaborate on research projects, fund preliminary pilot studies designed to advance human health or discuss commercialization opportunities.
Contact for General Questions
Director of Communications
Institute for Biomedical Sciences
Parker H. Petit Science Center
100 Piedmont Ave
Atlanta, GA 30303